Crown Equity Holdings Inc. (OTCBB :CRWE.OB) announced recently that its sales this year have already surpassed $1,000,000. This compares to $232,510 for the three quarters ending September 30, 2009 and $ 659,907 total sales for the year 2009.
Based on our sales to date, we had more than 4 times the sales for the same period last year and are 34% ahead of last year's total sales, commented Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. Our growth in sales along with our investments in infrastructure and people give the company a basis for supporting future growth of the magnitude we have seen so far this year, stated Bosket.
Crown Equity Holdings Inc. has expanded its internet footprint internationally to include the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, New Zealand, Singapore, Spain, Taiwan and the UK.
Legacy Reserves LP (Nasdaq:LGCY) todareported that the Board of Directors of its general partner has approved a cash distribution attributable to the third quarter of 2010 of $0.52 per unit, payable on November 12, 2010, to unitholders of record at the close of business on November 1, 2010.
This quarterly distribution represents an annualized distribution of $2.08 per unit and maintains the distribution amount paid for the tenth straight quarter.
OceanFirst Financial Corp. (Nasdaq:OCFC), the holding company for OceanFirst Bank, reported that net income available to common stockholders increased to $5.2 million for the quarter ended September 30, 2010 as compared to $5.0 million for the quarter ended June 30, 2010, and $4.0 million for the corresponding prior year period.
Diluted earnings per share for the quarter ended September 30, 2010 was $0.29, an increase of $0.02 from the prior linked quarter.
Center Bancorp, Inc. (Nasdaq:CNBC), parent company of Union Center National Bank (UCNB or the Bank), announced that on October 15, 2010, Stephen J. Mauger advised Center Bancorp, Inc., that he was resigning as Vice President, Treasurer & Chief Financial Officer of Center Bancorp, Inc. and as Senior Vice President and Chief Financial Officer of Union Center National Bank effective November 15, 2010, to pursue other opportunities.
MusclePharm Corporation (MSLP.OB),one of the fastest growing nutritional supplement company with a proprietary formulation used in its portfolio of performance products, announced recently that Ron Sekura, B.S., M.S., PhD., will join MusclePharm board of directors as its Director of Therapeutic Research. Dr. Sekura will be assisting in the development of MusclePharm'S therapeutic indication and application for patients with HIV experiencing catabolic cachexia.
MusclePharm is presently preparing their application for Recon to be added to the Medicaid formulary, beginning in New York State for people diagnosed with HIV and AIDS as well as nation-wide Veterans Administration therapeutic formularies. In addition, MusclePharm is exploring the distribution of MusclePharm products, such as Recon, to people living with HIV in developing nations thru The Global Fund to Fight AIDS, Tuberculosis and Malaria, and The Presidents Emergency Plan for AIDS Relief (PEPFAR). MusclePharm's Recon Nutritional Supplement contains important amino acids, which assists in reaching the higher levels of nutrition required for people living with HIV. It is easily digestible, helps the absorption of amino acids and proteins. Recon contains essential minerals, digestive enzymes, Glutamine and other metabolic agents that maximize recovery, protein synthesis and endurance.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB)